No Detail Found!

Kynurenine 3-Monooxygenase Protein and its Association on the Sleep Quality in Cigarette Smokers and Non-smokers

Author(s)
M. Binigha Department of Public Health Dentistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600 077, India
L. Leelavathi Department of Public Health Dentistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, 600 077, India
Selvaraj Jayaraman Centre of Molecular Medicine and Diagnostics, Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600 077, India
Abstract
Objectives: Background: Cigarette smoking significantly impacts sleep quality by altering neurochemical pathways. Nicotine, an agonist of nicotinic acetylcholine receptors, stimulates the release of dopamine, serotonin and norepinephrine, which can hinder the initiation and maintenance of sleep. This study focuses on the kynurenine pathway, where nicotine-induced Kynurenine 3-monooxygenase (KMO) activity leads to elevated levels of neurotoxic metabolites, such as quinolinic acid, that impair sleep quality in smokers. Methods: This cross-sectional study included 260 participants, equally divided into smokers and non-smokers, with informed consent obtained from all participants. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), covering parameters such as sleep latency, duration and disturbances. Saliva samples were collected and analyzed via ELISA to measure KMO biomarker levels. Statistical analyses, including Chi-Square and Mann-Whitney U tests, were employed to examine the relationship between KMO levels and sleep quality while acknowledging the limitations of selfreported data and potential confounders. Results: KMO levels were significantly higher in smokers (1.03 ± 0.13) compared to non-smokers (0.95 ± 0.09). Overall, 57.31% of participants reported good sleep, while 42.69% experienced poor sleep. Among smokers, 32.31% experienced poor sleep and only 17.69% had good sleep. Conversely, 39.62% of non-smokers reported good sleep, while 10.38% experienced poor sleep. Statistical analysis confirmed the association between smoking and disturbed sleep quality, though subgroup analyses by smoking intensity were not explored. Conclusion: The study confirms that smokers exhibit higher KMO levels and poorer sleep quality compared to non-smokers. These findings highlight the potential of targeting KMO levels as a therapeutic approach to mitigate sleep disturbances in smokers. Future research should explore pharmacological and behavioral interventions, while addressing broader public health implications and improving study methodologies.
Publication Details
Page(s) 1-5
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 7, Year: 2024

Request the full text from PASTIC

Keywords
Smokers, Sleep quality, Biomarkers, Nicotine dependency, non-smokers, KMO, neurotoxic metabolites
References
Purani ,Himal .2018 .Sleep quality in cigarette smokers: Associations with smoking-related outcomes and exercise. Addictive Behaviors, 10 : 71-76.
Frange C. .2023 .Clinical Cases in Sleep Physical Therapy. , : 300.
Wetter D.W.,Young T.B. .1994 .The relation between cigarette smoking and sleep disturbance. Preventive Medicine, 1046(3) : 328-334.
Hall F.,Scott F. .2015 .Negative affective states and cognitive impairments in nicotine dependence.”Neuroscience and Biobehavioral R e v i e w s , v o l . 5 8 , N o v e m b e r 2 0 1 5. , 06 : .
Grandner Michael A.,Sleep Michael A. .2019 .. , 534 : .
.2012 .[7] CDC. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Centers for Disease Control and Prevention, 22 : .
Silva .2022 .Sleep quality of adult tobacco users: A systematic review of literature and meta-analysis. ” Sleep Epidemiology, 100028 : .
Deatley ,Teresa ,April 2021 . .Psychometric analysis of a microenvironment secondhand smoke exposure questionnaire. International Journal of Environmental Research and Public Health, 18(7) : .
Aziz .2018 .Kynurenine 3-monooxygenase gene associated with nicotine initiation and addiction: Analysis of novel regulatory features at 5 and 3 -regions. , 00198 : .
Savitz ,April 2019 . .The kynurenine pathway: A finger in every pie. ” Molecular Psychiatry, 25(1) : 131-147.
Cohrs ,Stefan .2012 .Impaired sleep quality and sleep duration in smokers-results from the German Multicenter Study on Nicotine Dependence. Addiction Biology, 00487(3) : 1600-496.
Nivethitha R.,L. Leelavathi. “ R. .2022 .Awareness on ill effects of tobacco usage among tobacco users.” Journal of Advanced Pharmaceutical Te c h n o l o g y a n d R e s e a rch. , 147(1) : 22-S222.
Ahmed ,Naveed .2021 .Smoking a dangerous addiction: A systematic review on an underrated risk factor for oral diseases. International Journal of Environmental Research and Public Health, 10 : .
Jaehne ,Andreas .2012 .How smoking affects sleep: A polysomnographical analysis. ” Sleep Medicine, 06(10) : 1286-1292.
Sun Sijia,Li Sijia .2024 .“Exploring the relationship between smoking and poor sleep quality: A cross-sectional study using NHANES.” Frontiers in Psychiatry. , 1407741 : .
Phillips Barbara A.,April 1995 .1995 .Cigarette smoking and sleep disturbance. ” Archives of Internal Medicine, 00430070088011(7) : 734-737.
Schwarcz ,Robert . .Kynurenines in the mammalian brain: When physiology meets pathology. ” Nature Reviews Neuroscience, 13(7) : 465-477.
Ep ,April 2023 . .Inflammation in smokers and non-smokers during implant surgery among Indians. ” Bioinformation, 19(4) : 510-513.
Antony J.Vini,Mary J.Vini .2021 .Particle size, penetration rate and effects of smoke and smokeless tobacco products-an in vitro analysis. Heliyon, 10 : .
Ramalingam ,Karthikeyan .2023 .Assessment of oral lesions with tobacco usage: A cross-sectional clinicopathological study in Sri Ganganagar. , 10 : .
0

Citations

0

Downloads

34

Views